What is Proscia?
Picture a pathologist at a major cancer center sitting down to review a morning slate of biopsy cases. Instead of pulling glass slides from a tray and threading them through a microscope, she opens Proscia's Concentriq platform, where high-resolution whole slide images load in seconds alongside AI-generated annotations flagging regions of interest. That shift — from analog glass to collaborative digital — is what Proscia has spent a decade building toward, and in 2026, the company was named Global Best in KLAS for Digital Pathology in Europe with the top score in the U.S., based on direct customer feedback. Concentriq is the enterprise digital pathology platform supporting over 12,000 pathologists and scientists daily across diagnostic laboratories and life sciences organizations, including 16 of the top 20 global pharma companies. In March 2025, Proscia received FDA 510(k) clearance for Concentriq AP-Dx for primary diagnosis use, and in February 2026 raised $50M to expand AI-driven pathology capabilities. The platform functions as an open interoperability hub, allowing third-party AI applications covering different tissue types and cancer subtypes to run alongside Proscia's native algorithms — a key design choice that gives laboratory customers flexibility as the AI model landscape evolves. Beyond primary diagnosis workflows, Proscia Aperture extends the platform into precision medicine by turning diagnostic whole slide images into real-world evidence assets for drug development. Researchers can use tissue already reviewed at diagnosis to discover biomarkers, train new AI models, and set clinical trial endpoints — compressing the gap between pathology departments and life sciences R&D pipelines. Concentriq is not the right tool for laboratories still operating on low-volume glass slide workflows without digital scanner infrastructure. Transitioning to the platform requires whole slide imaging hardware investment and an IT deployment project, making it most applicable to health systems and reference labs already committed to or actively planning digital conversion.
Proscia's Concentriq platform delivers AI-powered digital pathology for cancer diagnostics and drug development, used by 12,000+ pathologists at leading pharma organizations.
Proscia is widely used by professionals, developers, marketers, and creators to enhance their daily work and improve efficiency.
Key Features
Pros & Cons
Who Uses Proscia?
Proscia vs MyMap AI vs GPT for Sheets and Docs vs Pabbly Connect
Detailed side-by-side comparison of Proscia with MyMap AI, GPT for Sheets and Docs, Pabbly Connect — pricing, features, pros & cons, and expert verdict.
| Compare | ||||
|---|---|---|---|---|
Pricing |
unknown | Freemium | Freemium | Freemium |
Rating |
— | — | — | — |
Free Trial |
✕ | ✓ | ✓ | ✓ |
Key Features |
|
|
|
|
Pros |
AI-generated quantitative annotations reduce inter-path Replaces physical slide transport, manual retrieval fro Cloud-native deployment supports both small specialty l | Converting a 30-page document or a complex topic descri The chat-based creation model means there is no interfa MyMap accepts source material from text, documents, URL | Running a language model prompt across an entire Google The freemium model provides access to base AI processin The add-on integrates as a standard Google Workspace si | Features a logical, step-by-step wizard that simplifies The lifetime deal provides massive long-term ROI, espec Backed by an active Facebook group of 21,000+ members a |
Cons |
Full Proscia deployment requires compatible whole slide Pathologists transitioning from glass slide workflows t Concentriq's AI analysis capabilities are entirely depe | The chat-based creation model is intuitive for simple d MyMap AI requires an active internet connection for all MyMap's AI-driven layout produces diagrams that are str | While the formula syntax is straightforward, writing ef GPT-4 Turbo and Claude 3 model calls generate token-bas GPT for Sheets and Docs operates exclusively within Goo | While no-code, mastering the logic of deep routers and While it covers 2,000+ apps, some niche enterprise trig Workflow reliability is tied to the API stability of th |
Best For |
Hospital Pathology Departments | Students & Researchers | Content Creators | Small to Medium-Sized Businesses |
Verdict |
For hospital pathology departments and pharma research teams… | MyMap AI is the most accessible entry point for AI-generated… | For e-commerce managers, data analysts, and content teams wh… | Pabbly Connect is the 'utility player' of the automation wor… |
Try It |
Visit Proscia ↗ | Visit MyMap AI ↗ | Visit GPT for Sheets and Docs ↗ | Visit Pabbly Connect ↗ |
Proscia vs MyMap AI vs GPT for Sheets and Docs vs Pabbly Connect — Which is Better in 2026?
Choosing between Proscia, MyMap AI, GPT for Sheets and Docs, Pabbly Connect can be difficult. We compared these tools side-by-side on pricing, features, ease of use, and real user feedback.
Proscia vs MyMap AI
Proscia — Proscia is an AI Tool that has earned the top KLAS score in digital pathology for 2026, reflecting the trust of 12,000+ daily users across diagnostic labs and p
MyMap AI — MyMap AI is an AI Tool that generates diagrams and mind maps from conversational input, uploaded files, URLs, and live web search results. Its chat-native desig
- Proscia: Best for Hospital Pathology Departments, Research Institutions, Biotech Companies, Educational Facilities, Un
- MyMap AI: Best for Students & Researchers, Professionals, Content Creators, Educators, Uncommon Use Cases
Proscia vs GPT for Sheets and Docs
Proscia — Proscia is an AI Tool that has earned the top KLAS score in digital pathology for 2026, reflecting the trust of 12,000+ daily users across diagnostic labs and p
GPT for Sheets and Docs — GPT for Sheets and Docs is an AI Tool that brings multiple AI language models into Google Sheets and Docs through a simple add-on installation, enabling bulk te
- Proscia: Best for Hospital Pathology Departments, Research Institutions, Biotech Companies, Educational Facilities, Un
- GPT for Sheets and Docs: Best for Content Creators, Data Analysts, E-commerce Managers, Marketers, Uncommon Use Cases
Proscia vs Pabbly Connect
Proscia — Proscia is an AI Tool that has earned the top KLAS score in digital pathology for 2026, reflecting the trust of 12,000+ daily users across diagnostic labs and p
Pabbly Connect — Pabbly Connect is a high-value automation engine that disrupts the market with its 'pay-once' lifetime model. By offering 2,000+ integrations and a generous pol
- Proscia: Best for Hospital Pathology Departments, Research Institutions, Biotech Companies, Educational Facilities, Un
- Pabbly Connect: Best for Small to Medium-Sized Businesses, E-commerce Platforms, Marketing Agencies, Freelancers, Uncommon Us
Final Verdict
For hospital pathology departments and pharma research teams that need a single enterprise platform covering primary diagnosis, AI algorithm deployment, and biomarker discovery, Proscia Concentriq delivers the most validated clinical pathway in digital pathology in 2026 — the primary limitation is that full deployment requires digital scanning infrastructure investment that smaller community laboratories may not yet have in place.
FAQs
4 questionsExpert Verdict
Summary
Proscia is an AI Tool that has earned the top KLAS score in digital pathology for 2026, reflecting the trust of 12,000+ daily users across diagnostic labs and pharma research organizations. Its Concentriq platform connects primary diagnosis workflows with AI model deployment and precision medicine data pipelines, making it one of the few pathology platforms that serves both clinical and life sciences use cases at enterprise scale. The $50M 2026 funding round signals continued investment in expanding the AI algorithm catalog and cloud deployment capacity.
It is suitable for beginners as well as professionals who want to streamline their workflow and save time using advanced AI capabilities.